Cargando…
Placental effects and transfer of sildenafil in healthy and preeclamptic conditions
BACKGROUND: The phosphodiesterase-5 inhibitor (PDE5) sildenafil has emerged as a promising treatment for preeclampsia (PE). However, a sildenafil trial was recently halted due to lack of effect and increased neonatal morbidity. METHODS: Ex vivo dual-sided perfusion of an isolated cotyledon and wire-...
Autores principales: | Hitzerd, Emilie, Broekhuizen, Michelle, Mirabito Colafella, Katrina M., Glisic, Marija, de Vries, René, Koch, Birgit C.P., de Raaf, Michiel A., Merkus, Daphne, Schoenmakers, Sam, Reiss, Irwin K.M., Danser, A.H. Jan, Simons, Sinno H.P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642075/ https://www.ncbi.nlm.nih.gov/pubmed/31204276 http://dx.doi.org/10.1016/j.ebiom.2019.06.007 |
Ejemplares similares
-
Pentoxifylline as a therapeutic option for pre‐eclampsia: a study on its placental effects
por: Broekhuizen, Michelle, et al.
Publicado: (2022) -
The Function of the Kynurenine Pathway in the Placenta: A Novel Pharmacotherapeutic Target?
por: Broekhuizen, Michelle, et al.
Publicado: (2021) -
Larger First-Trimester Placental Volumetric Parameters Are Associated With Lower Pressure and More Flow-Mediated Vasodilation of the Fetoplacental Vasculature After Delivery
por: Hitzerd, Emilie, et al.
Publicado: (2020) -
The Placental Innate Immune System Is Altered in Early-Onset Preeclampsia, but Not in Late-Onset Preeclampsia
por: Broekhuizen, Michelle, et al.
Publicado: (2021) -
Differences in Placental Imprinted Gene Expression across Preeclamptic and Non-Preeclamptic Pregnancies
por: Deyssenroth, Maya A., et al.
Publicado: (2020)